• Christine Chordas
Part of the Pediatric Oncology book series (PEDIATRICO, volume 22)


Acute Lymphocytic Leukemia Home Care Childhood Cancer Personal Protective Equipment Hemorrhagic Cystitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Albanell, J., Baselga J. (2000). Systemic therapy emergencies. Seminars in Oncology Nursing. 7(3):347–361Google Scholar
  2. Balinsky, W. (1995). High tech home care. Caring, 14(5):7–9Google Scholar
  3. Beason, R. (1990). Antineoplastic vesicant extravasation. Journal of Intravenous Nursing, 13(2):111–114PubMedGoogle Scholar
  4. Bernstein, M.L., Reaman, G.H., Hirschfeld S. (2001). Developmental therapeutics in childhood cancer. Hematology Oncology Clinics of North America, 15:631–655Google Scholar
  5. Bryant, R. (2001). Use of a protocol to minimize hypersensitivity reactions with asparaginase administration. Journal of Intravenous Nursing, 4:169–173Google Scholar
  6. Camp-Sorrell, D. (1998). Developing extravasation protocols and monitoring outcomes. Journal of Intravenous Nursing, 1:232–239Google Scholar
  7. Carr, B., Burke, C. (2001). Outpatient chemotherapy hypersensitivity and anaphylaxis. American Journal of Nursing, 27–30Google Scholar
  8. Chapman, D. (1998). Family-focused pediatric home care. Caring 17(5):12–15Google Scholar
  9. Ciesielski-Carlucci, C., Leong, P., Jacobs, C. (1997). Case report of anaphylaxis from cisplatin/paclitaxel and a review of their hypersensitivity reaction profiles. American Journal of Clinical Oncology, 20:373–375PubMedGoogle Scholar
  10. Close, P., Burkey, E., Kazak, A. Danz, P., Lange, B. (1995). A prospective, controlled evaluation of home chemotherapy for children with cancer. Pediatrics, 95(6):896–900PubMedGoogle Scholar
  11. Deitcher, S.R., Fesen, M.R., Kiproff, P.M., Hill, P.A., Li, X., McCluskey, E.R., Semba, C.P. (2002a). Safety and efficacy of alteplase for restoring function in occluded central venous catheters: Results of the cardiovascular thrombolytic to open occluded line trial. Journal of Clinical Oncology, 20(1)Google Scholar
  12. Ettinger, A.G., Bond, D.M., Sievers, T.D. (2002). Chemotherapy. In Baggot C.R., Kelly K.P., Fochtman D., Foley G.V. (eds) Nursing Care of Children and Adolescents with Cancer, pp. 133–176. Philadelphia: WB SaundersGoogle Scholar
  13. Goodman, M. (2000). Chemotherapy: Principles of administration. In Yarbro C.H, Frogge M.H., Goodman M., Groenwald S. (eds) Cancer Nursing: Principles and Practice, pp. 385–443. Boston: Jones and BartlettGoogle Scholar
  14. Harrison, B.R. (1996.) Safe handling of cytotoxic drugs. In Perry M.C. (ed) The Chemotherapy Source Book, 2nd edn. Baltimore: Williams & WilkinsGoogle Scholar
  15. Kassner, E. (2002). Evaluation and treatment of chemotherapy extravasation injuries. Journal of Pediatric Oncology Nursing, 17(3):135–148Google Scholar
  16. Labovich, T.M. (1999). Acute hypersensitivity reactions to chemotherapy. Seminars in Oncology Nursing, 15(3):222–231PubMedGoogle Scholar
  17. Meeske, K., Ruccione, K. (1987) Cancer chemotherapy in children: nursing issues and approaches. Seminars in Oncology Nursing, 3:122Google Scholar
  18. National Association of Children’s Hospitals and Related Institutions (NACHRI) Patient Care Oncology FOCUS Group (2000). Home care requirements for children and adolescents with cancer. Journal of Pediatric Oncology Nursing, 17:45–49Google Scholar
  19. Occupational Safety and Health Administration: Guidelines for Cytotoxic Drugs (OSHA Directive PUB 8-1.1). Washington, DC, US Department of Labor. Retrieved from the WWW 3/6/2002. Scholar
  20. Oncology Nursing Society (2001) ONS Chemotherapy and Biotherapy: Guidelines and Recommendations for Practice. Pittsburg: Oncology Nursing Society Press. (pp. 65–68)Google Scholar
  21. San Angel F (1995) Current controversies in chemotherapy administration. Journal of IV Nursing 18(1):16–23Google Scholar
  22. Schiavetti, A., Varrasso, G., Maurizi, P., Castello, M. (1999). Hypersensitivity to carboplatin in children. Medical and Pediatric Oncology, 3:183–185Google Scholar
  23. Schulmeister, L., Camp-Sorrell, D. (2000). Chemotherapy extravasation from implanted ports. Oncology Nursing Forum, 7:531–538Google Scholar
  24. Tariman, J.D. (2003). Thalidomide: current therapeutic uses and management or its toxicities. Clinical Journal of Oncology Nursing, 7:143–147PubMedGoogle Scholar
  25. Weiss, R. (1997). Hypersensitivity reactions. In Perry M. (ed) The Chemotherapy Source Book, 2nd edn. Williams & WilkinsGoogle Scholar
  26. Wilson, D., Perry K. A. (1999). Pediatric variations of nursing interventions. In Wong D. L, Hockenberry-Eaton M., Wilson D., M. Winkelstein L., Ahmann E. (eds) Whaley & Wong’s Nursing Care of Infants and Children, 6th edn. St. Louis: MosbyGoogle Scholar
  27. Yu, D., Dahl, G., Shames, R., Fisher, P. (2001). Weekly dosing of carboplatin Increased risk of allergy in children. Journal of Pediatric Hematology Oncology, 3(6):349–352Google Scholar
  28. Balis, F.M., Holcenberg, J.S., Blaney, S.M. (2002). In Pizzo P., Poplack D. (eds) Principles and Practice of Pediatric Oncology, pp. 237–308. Lippincott William & WilkinsGoogle Scholar
  29. Bertilli, G., Gozza, A., Forno, G.B., Vidili, M.G., Silvestro, S., Venturini, M., Del Mastro, L., Garrone, O., Rosso, R., Dini, D. (1995). Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: A prospective clinical study. Journal of Clinical Oncology, 13:2851–2855PubMedGoogle Scholar
  30. Boyle, D.M., Engelking, C. (1995). Vesicant extravasation myths and realities. Oncology Nursing Forum, 22:57–67PubMedGoogle Scholar
  31. Bomgaars, L., Berg, S.L., Blaney, S.M. (2001). The development of camptothecin analogs in childhood cancers. The Oncologist, 6:506–516PubMedGoogle Scholar
  32. Deitcher, S., Fesen, M., Kiproff, P., Hill, P., Li, X., McCluskey, E., Semba, C., Frierdich, S. (2002b). Home Care. In Baggot C.R., Kelly K.P., Fochtman D., Foley G.V. (eds), Nursing Care of Children and Adolescents with Cancer, pp. 391–399. Philadelphia: W.B. SaundersGoogle Scholar
  33. Durivage, H., Fischer, D., Knobf, M.(1993). The Cancer Chemotherapy Handbook, 4th edn. St. Louis: MosbyGoogle Scholar
  34. Godson, E. (1997). Behavioral disorders and developmental variations. In Hay, W.W., Groothuis J.R., Hayward, A. R., Levin, M. J. (eds) Current: Pediatric Diagnosis and Treatment, pp. 77–85. Connecticut: Appleton & LangeGoogle Scholar
  35. Gorski, L.A., Grothman, L. (1995). Home infusion therapy. Seminars in Oncology Nursing, 1(3), 193–201Google Scholar
  36. Haugen, M., Nuuhhiwa, J. (2002, October). Home alone: safety issues in home chemotherapy administration. Paper presented at the meeting of the Association of Pediatric Oncology Nurses 6th Annual Conference, Denver, COGoogle Scholar
  37. Hockenberry, M., Kline, N. (2002). Nursing support of the child with cancer. In Pizzo P., Poplack D. (eds) Principles and Practice of Pediatric Oncology (pp. 134–1343). Lippincott William & WilkinsGoogle Scholar
  38. Holdsworth, M., Raisch, D., Chavez, C., Duncan, M., Parasuraman, T., Cox, F. (1997). Economic impact with home delivery of chemotherapy to pediatric oncology patients. The Annals of Pharmacotherapy, 31:140–148PubMedGoogle Scholar
  39. Hooke, C., Ellingson, L. (1999). Ifosfamide and etoposide: Moving 5-day infusions from inpatient to outpatient. Paper presented at the meeting of the Association of Pediatric Oncology Nurses 2nd Annual ConferenceGoogle Scholar
  40. Hooker L., Kohler, J. (1999). Safety, efficacy and acceptability of home intravenous therapy administered by parents of pediatric oncology patients. Medical Pediatric Oncology, 3:421–426Google Scholar
  41. Jacob, E. (2000). Continuing care of the newly diagnosed child with cancer from hospital to home: Part1. Home Health Care Consultant, 7(6):1A–11AGoogle Scholar
  42. Joint Commission of Accreditation of Hospital Organizations. (2001). 2001–2002 Comprehensive Accreditation Manual for Home Care. Oakbrook Terrace, Il: Joint Commission ResourcesGoogle Scholar
  43. Joint Commission of Accreditation of Hospital Organizations. (2001). The complete guide to the 20021–2002 Home Care Survey Process: Home Health Personal Care, support and Hospice Services. Oakbrook Terrace, IL: Joint Commission ResourcesGoogle Scholar
  44. Lawrence, H.J, Walsh, D. (1989). Topical dimethylsulfoxide may prevent tissue damage from anthracycline extravasation. Cancer Chemotherapy Pharmacology, 3(5):316–318Google Scholar
  45. Lopez, A.M., Wallace, L., Dorr, R.T., Koff, M., Hersh, E.M., Alberts, D.S. (1999). Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodyesthesia. Cancer Chemotherapy Pharmacology, 44:303–306Google Scholar
  46. Martingano, E.C., Ethier, A. (1997). Anaphylaxis to asparaginase preparations: development of a protocol. Leukemia Nursing, 1:6Google Scholar
  47. Moran, P. (2000). Cellular effects of cancer chemotherapy administration. Journal of IV Nursing, 3(1):44–56Google Scholar
  48. Ogle, S., Rose, M., Wildes, C. (2002). Development and implementation of a carboplatin desensitization protocol for children with neurofibromatosis, type 1 and hypersensitivity reactions in an outpatient oncology clinic. Journal of Pediatric Oncology Nursing, 19:122–126PubMedGoogle Scholar
  49. Rollins, J.A. (1999). Family centered care of the child during illness and hospitalization. In Wong D.L, Hockenberry-Eaton M., Wilson D., M. Winkelstein L., Ahmann E. (eds) Whaley & Wong’s Nursing Care of Infants and Children, pp. 1131–1209Google Scholar
  50. Stricklan, L. (ed) (2000). St. Jude Children’s Research Hospital Formulary Handbook. Hudson, OH: Lexi-CompGoogle Scholar
  51. Taketomo, C.K., Hodding, J.H., Kraus, D.M. (2002). Pediatric Dosage Handbook, 8th edn. Hudson, Ohio: Lexi-CompGoogle Scholar
  52. Weaver, J., Simmons, G., Scholfield, R. (1995). The home infusion formula: high tech + high touch = high-quality home care. Caring, 52–56Google Scholar
  53. Wilkes, G.M., Ingwersen, K., Barton-Burke, M. (2000). Oncology Nursing Drug Handbook. Boston: Jones and BartlettGoogle Scholar
  54. Wilson, K. (1998). Oncologic emergencies. In Hockenberry-Eaton M. (ed) Essentials of Pediatric Oncology Nursing: A Core Curriculum. Glenview: Association of Pediatric Oncology NursesGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Christine Chordas

There are no affiliations available

Personalised recommendations